Algert Global LLC Si Bone, Inc. Transaction History

Algert Global LLC

$4.77 Billion
Q2 2025

A detailed history of Algert Global LLC transactions in Si Bone, Inc. stock. As of the latest transaction made, Algert Global LLC holds 203,019 shares of SIBN stock, worth $3.09 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

203,019

Holding current value

$3.09 Million

% of portfolio

0.08%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$13.05 - $19.71 $2.65 Million - $4 Million	203,019 New	203,019 $3.82 Million
Q3 2023 Nov 13, 2023	SELL	$20.22 - $27.36 $1.85 Million - $2.51 Million	-91,670 Reduced 78.05%	25,776 $547,000
Q2 2023 Aug 14, 2023	BUY	$19.39 - $28.9 $1.38 Million - $2.05 Million	71,030 Added 153.03%	117,446 $3.17 Million
Q1 2023 May 12, 2023	BUY	$12.71 - $21.17 $149,787 - $249,488	11,785 Added 34.03%	46,416 $913,000
Q4 2022 Feb 13, 2023	BUY	$11.23 - $19.44 $274,169 - $474,608	24,414 Added 238.95%	34,631 $471,000
Q3 2022 Nov 15, 2022	SELL	$12.2 - $18.71 $13,139 - $20,150	-1,077 Reduced 9.54%	10,217 $178,000
Q1 2022 May 16, 2022	SELL	$18.32 - $23.03 $474,652 - $596,684	-25,909 Reduced 69.64%	11,294 $255,000
Q4 2021 Feb 14, 2022	BUY	$18.75 - $24.8 $118,687 - $156,984	6,330 Added 20.5%	37,203 $826,000
Q3 2021 Nov 15, 2021	BUY	$19.65 - $31.89 $373,605 - $606,324	19,013 Added 160.31%	30,873 $661,000
Q2 2021 Aug 13, 2021	BUY	$29.4 - $35.96 $80,850 - $98,890	2,750 Added 30.19%	11,860 $373,000
Q1 2021 May 14, 2021	BUY	$28.09 - $34.02 $55,056 - $66,679	1,960 Added 27.41%	9,110 $290,000
Q4 2020 Feb 12, 2021	BUY	$20.44 - $30.88 $146,146 - $220,792	7,150 New	7,150 $214,000

Others Institutions Holding SIBN

# of Institutions

187

Shares Held

43M

Call Options Held

62.9K

Put Options Held

View Full List

About SI-BONE, Inc.

Ticker SIBN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,305,000
Market Cap $522M
Description
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...

More about SIBN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account